SUPREME-HN: a retrospective biomarker study assessing the prognostic value of PD-L1 expression in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

BACKGROUND: Programmed cell death ligand-1 (PD-L1) expression on tumor cells (TCs) is associated with improved survival in patients with head and neck squamous cell carcinoma (HNSCC) treated with immunotherapy, although its role as a prognostic factor is controversial. This study investigates whethe...

Descripción completa

Detalles Bibliográficos
Autores principales: Pai, Sara I., Cohen, Ezra E. W., Lin, Derrick, Fountzilas, George, Kim, Edward S., Mehlhorn, Holger, Baste, Neus, Clayburgh, Daniel, Lipworth, Loren, Resteghini, Carlo, Shara, Nawar, Fujii, Takashi, Zhang, Jun, Stokes, Michael, Wang, Huifen, Twumasi-Ankrah, Philip, Wildsmith, Sophie, Khaliq, Asud, Melillo, Giovanni, Shire, Norah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933901/
https://www.ncbi.nlm.nih.gov/pubmed/31878938
http://dx.doi.org/10.1186/s12967-019-02182-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933901/
https://www.ncbi.nlm.nih.gov/pubmed/31878938
http://dx.doi.org/10.1186/s12967-019-02182-1

Ejemplares similares